ZLAB Zai Lab Limited
Healthcare$18.45-0.86%ClosedMarket Cap: $2.07B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.13
P/S
4.65
EV/EBITDA
-8.18
DCF Value
$-74.02
FCF Yield
-5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.9%
Operating Margin
-53.5%
Net Margin
-39.3%
ROE
-24.3%
ROA
-16.2%
ROIC
-26.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $99.6M | 61.5% | $-69.3M | $-51.0M | $— | — |
| Q4 null | $127.6M | 51.2% | $-69.4M | $-50.4M | $— | — |
| FY null | $460.2M | 58.5% | $-223.6M | $-175.5M | $— | — |
| Q3 null | $116.1M | 59.6% | $-48.8M | $-36.0M | $— | — |
| Q2 null | $110.0M | 60.7% | $-54.9M | $-40.7M | $— | — |
| Q1 null | $106.5M | 63.7% | $-56.3M | $-48.4M | $— | — |
| Q4 null | $109.1M | 61.4% | $-67.9M | $-81.7M | $— | — |
| FY null | $399.0M | 62.9% | $-282.1M | $-257.1M | $— | — |
| Q3 null | $102.3M | 63.9% | $-67.9M | $-41.7M | $— | — |
| Q2 null | $100.5M | 64.9% | $-76.1M | $-80.3M | $— | — |
| Q1 null | $87.1M | 61.4% | $-70.3M | $-53.5M | $— | — |
| Q4 2023 | $65.8M | 61.7% | $-124.0M | $-95.4M | $-9.80 | — |